{"id":"https://genegraph.clinicalgenome.org/r/582a82c8-8e44-4086-bfb5-4989eaabfe2fv1.1","type":"EvidenceStrengthAssertion","dc:description":"Variants in HOXA1 were first reported in humans with autosomal recessive syndromic intellectual disability as early as 2003 (Holve et al., PMID:12833395). Evidence supporting this gene-disease relationship includes case-level data and experimental data. At least 4 variants (e.g. nonsense and frameshift) have been reported in humans. Variants in this gene have been reported in at least 16 probands in 3 publications (12833395, 16155570, 18412118). Variants in this gene segregated with disease in 8 additional family members. All affected individuals identified thus far are Saudi Arabian, Turkish, or Native American, and the authors asserted that the variants associated were likely founder variants. The mechanism for disease is homozygous loss of function. Of note, this gene has also been implicated in brain malformation. This will be assessed separately. This gene-disease association is supported by expression studies and animal models. In summary, HOXA1 is definitively associated with autosomal recessive syndromic intellectual disability. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on 6/19/19 (SOP Version 6).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/582a82c8-8e44-4086-bfb5-4989eaabfe2f","GCISnapshot":"https://genegraph.clinicalgenome.org/r/1e0e605f-c82a-4e34-b913-8dc6b72b4881","calculatedEvidenceStrength":"Definitive","changes":[{"id":"cg:otherTextChange"},{"id":"cg:summaryChange"}],"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/1e0e605f-c82a-4e34-b913-8dc6b72b4881_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2021-10-28T15:59:46.215Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/1e0e605f-c82a-4e34-b913-8dc6b72b4881_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2019-06-19T16:00:00.000Z","role":"Approver"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1e0e605f-c82a-4e34-b913-8dc6b72b4881_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1e0e605f-c82a-4e34-b913-8dc6b72b4881_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/00ac12aa-051d-4638-86b0-fbe74ed9c262","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b7fc763d-ba71-47b2-a034-6ff8d9c182f5","type":"Finding","dc:description":"In situ hybridization of Hox-1.6 in mouse embryonic sections showed that its gene expression is first detected at 7.5 days during the early stages of gastrulation within the primitive streak in newly formed mesoderm and overlying neuroectoderm. In an 8 day embryo, Hox-1.6 is expressed at a high level extending from the posterior end of the embryo along the neuroectoderm and mesoderm tissue layers into the region of the developing hindbrain of the headfold. Between 9 and 10 days, Hox-1.6 is expressed within the neural tube in posterior regions only.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/1673098","rdfs:label":"In situ hybridization","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/1e0e605f-c82a-4e34-b913-8dc6b72b4881_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0a603976-3d96-4823-af43-1bed10f776b4","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e9aa1c4c-cc88-42cc-a0a0-59cd28819a3a","type":"Finding","dc:description":"The Hox-1.6 KO mouse share similar brain malformation features with BSAS patients, including absence of certain cranial nerves and malformation of the inner ear.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/1680563","rdfs:label":"Neural anatomy","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/1e0e605f-c82a-4e34-b913-8dc6b72b4881_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/890f8751-4ea0-4102-b566-8fbe72dfc6a8_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/890f8751-4ea0-4102-b566-8fbe72dfc6a8","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12833395","rdfs:label":"Patient 1","allele":{"id":"https://genegraph.clinicalgenome.org/r/741b5bc7-c418-407b-830d-4c684a500157","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005522.5(HOXA1):c.76C>T (p.Arg26Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA124439"}},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Horizontal gaze palsy, seizure","phenotypes":["obo:HP_0001263","obo:HP_0001604","obo:HP_0000407","obo:HP_0007110","obo:HP_0007209"],"previousTesting":false,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/37c2b079-0d83-461f-b778-ce41f473bfa7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12833395","allele":{"id":"https://genegraph.clinicalgenome.org/r/741b5bc7-c418-407b-830d-4c684a500157"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/37c2b079-0d83-461f-b778-ce41f473bfa7","type":"EvidenceLine","dc:description":"Downgrading to be consistent with scoring in SOP version 6.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/37c2b079-0d83-461f-b778-ce41f473bfa7_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/1e0e605f-c82a-4e34-b913-8dc6b72b4881_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/17cd6d1e-27e9-4a3f-96a4-4c2cb10b2b86_family_segregation","type":"FamilyCosegregation","dc:description":"The authors only sequenced HOXA1 gene in the linkage region, given similarities between the BSAS phenotype and the pathology of the Hoxa1 KO mouse.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16155570","rdfs:label":"Pedigree KF","family":{"id":"https://genegraph.clinicalgenome.org/r/17cd6d1e-27e9-4a3f-96a4-4c2cb10b2b86","type":"Family","rdfs:label":"Pedigree KF"},"meetsInclusionCriteria":true,"phenotype":[{"id":"obo:HP_0001270"},{"id":"obo:HP_0000407"}],"phenotypeFreeText":"Horizontal gaze restriction","phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":3,"publishedLodScore":7.7,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/69154bdf-41c4-4dde-8362-60d4fc1b50f0_proband_segregation","type":"FamilyCosegregation","dc:description":"This family only had one affected individual.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16155570","rdfs:label":"Pedigree CR","estimatedLodScore":0.25,"family":{"id":"https://genegraph.clinicalgenome.org/r/69154bdf-41c4-4dde-8362-60d4fc1b50f0","type":"Family","rdfs:label":"Pedigree CR","member":{"id":"https://genegraph.clinicalgenome.org/r/229925e5-51c0-4e2e-84d2-7cbcc4ef3802","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16155570","rdfs:label":"CR","allele":{"id":"https://genegraph.clinicalgenome.org/r/8d446ba9-7fd8-452e-80a1-b2f48bfe3808","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005522.5(HOXA1):c.84C>G (p.Tyr28Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA124437"}},"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/41d47b01-c5e5-429c-aa4f-ed440271e768_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16155570","allele":{"id":"https://genegraph.clinicalgenome.org/r/8d446ba9-7fd8-452e-80a1-b2f48bfe3808"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Horizontal gaze restriction","phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0001270","obo:HP_0000407"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/229925e5-51c0-4e2e-84d2-7cbcc4ef3802"}},{"id":"https://genegraph.clinicalgenome.org/r/38a55ce0-fcac-47f2-9665-f62b3af8676b_proband_segregation","type":"FamilyCosegregation","dc:description":"As affected by an autosomal recessive condition, this family has only 2 affected individuals.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16155570","rdfs:label":"Pedigree LG","estimatedLodScore":1.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/38a55ce0-fcac-47f2-9665-f62b3af8676b","type":"Family","rdfs:label":"Pedigree LG","member":{"id":"https://genegraph.clinicalgenome.org/r/e683be84-7da6-45af-83d2-28b738b54a5e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16155570","rdfs:label":"LG_IV","allele":{"id":"https://genegraph.clinicalgenome.org/r/abff4a4e-701f-4e14-8624-240caec2b462","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005522.4(HOXA1):c.175dup (p.Val59GlyfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA4196017"}},"phenotypeFreeText":"Horizontal gaze restriction, mental retardation","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/60ad0296-78ae-4900-be44-37cd84fae986_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16155570","allele":{"id":"https://genegraph.clinicalgenome.org/r/abff4a4e-701f-4e14-8624-240caec2b462"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Horizontal gaze restriction","phenotypeNegativeAlleleNegative":8,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0001270","obo:HP_0000407"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/e683be84-7da6-45af-83d2-28b738b54a5e"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/229925e5-51c0-4e2e-84d2-7cbcc4ef3802_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/229925e5-51c0-4e2e-84d2-7cbcc4ef3802"},{"id":"https://genegraph.clinicalgenome.org/r/41d47b01-c5e5-429c-aa4f-ed440271e768","type":"EvidenceLine","dc:description":"Downgrading to be consistent with scoring in SOP version 6.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/41d47b01-c5e5-429c-aa4f-ed440271e768_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/1635ad3a-e5f0-4d67-807d-e7765f13c0ad_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1635ad3a-e5f0-4d67-807d-e7765f13c0ad","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18412118","rdfs:label":"A1","allele":{"id":"https://genegraph.clinicalgenome.org/r/e94cd39d-21fe-4613-a8fa-0bc4f1b91845","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005522.4(HOXA1):c.185del (p.Gly62ValfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA891862625"}},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Horizontal gaze restriction","phenotypes":"obo:HP_0000407","previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/b6ba652b-e3fb-4e22-81fe-6567ee5725f2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18412118","allele":{"id":"https://genegraph.clinicalgenome.org/r/e94cd39d-21fe-4613-a8fa-0bc4f1b91845"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/b6ba652b-e3fb-4e22-81fe-6567ee5725f2","type":"EvidenceLine","dc:description":"Downgrading to be consistent with scoring in SOP version 6.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b6ba652b-e3fb-4e22-81fe-6567ee5725f2_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/e683be84-7da6-45af-83d2-28b738b54a5e_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e683be84-7da6-45af-83d2-28b738b54a5e"},{"id":"https://genegraph.clinicalgenome.org/r/60ad0296-78ae-4900-be44-37cd84fae986","type":"EvidenceLine","dc:description":"Downgrading to be consistent with scoring in SOP version 6.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/60ad0296-78ae-4900-be44-37cd84fae986_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":9.5}],"evidenceStrength":"Definitive","sequence":3573,"specifiedBy":"GeneValidityCriteria6","strengthScore":12,"subject":{"id":"https://genegraph.clinicalgenome.org/r/55Yl1MqOeao","type":"GeneValidityProposition","disease":"obo:MONDO_0000508","gene":"hgnc:5099","modeOfInheritance":"obo:HP_0000007"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_1e0e605f-c82a-4e34-b913-8dc6b72b4881-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}